Working… Menu

Platelet Inhibition in Patients With Systolic Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01765400
Recruitment Status : Completed
First Posted : January 10, 2013
Last Update Posted : October 2, 2017
Daiichi Sankyo, Inc.
Eli Lilly and Company
Information provided by (Responsible Party):
Paul Dobesh, PharmD, University of Nebraska

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : December 1, 2015
Actual Study Completion Date : December 28, 2015
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 16, 2018
February 12, 2018